
Wegovy Linked to Rare 'Eye Stroke' That Can Cause Sudden Blindness
0:00
6:41
- Researchers found that Wegovy showed the strongest reported association with a rare optic nerve injury that can cause sudden vision loss, raising new questions about the safety of high-dose semaglutide formulations
- Men using Wegovy showed the highest reported risk in the FDA safety database, with odds of optic nerve injury appearing substantially higher than those reported for women
- Analysis of more than 400,000 online discussions revealed that many GLP-1 users frequently reported fatigue, low energy, menstrual changes, chills and hot flashes — symptoms that receive far less attention than digestive side effects
- Real-world patient conversations and artificial intelligence analysis are helping researchers identify emerging drug safety signals much faster than conventional reporting systems alone
- Your body already produces its own GLP-1 hormone through gut microbes that generate butyrate, and restoring this natural system through better gut health supports appetite control and metabolic function without relying on injections
Więcej odcinków z kanału "Dr. Joseph Mercola - Take Control of Your Health"



Nie przegap odcinka z kanału “Dr. Joseph Mercola - Take Control of Your Health”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








